drugset / Trial / NCT04316676

The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI

NCT04316676

NaSingle-groupOpen-labelDiagnostic

Summary

The overall goal of this project is to compare the absolute quantification of myocardial perfusion done by using CT myocardial perfusion imaging (CT-MPI) and the coronary flow measured by using CT Fractional Flow Reserve analysis (CT-FFR) to the gold standard represented by PET myocardial perfusion imaging (PET-MPI).

Timeline

Start
2021-06-16
Primary completion
2024-09-24
Completion
2024-09-24

Drugs

EvaluationDrugModalityDoseRoute
Background Regadenoson Diagnostic / imaging agent 0.4 mg